Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Tomas J. Svoboda, CEO, Elanix Biotechnologies
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Introduction to Elanix Biotechnologies by Tomas J. Svoboda, CEO
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Geoff Yang on AI's Rise: Transformative Trends in Technology and Investment | Geoff Yang, Co-Founder, Redpoint Ventures.
00:10:00
How to Handle Insurance Conversations After an Accident: Key Tip
00:10:00
Abingdon Health CEO Chris Yates Discusses London Listing and Growth Strategy | Chris Yates, CEO, Abingdon Health PLC.
00:10:00
Navigating M&A Auctions: Insights from Corinthian Capital's Adam Fitz
00:10:00
Business Interview: Rodolfo de Benedetti, CEO of CIR Group
00:10:00
David Hampstead on Samarkand Global's Strategic Partnership with S.F. Holding and Recent Brand Acquisitions | David Hampstead, CEO , Samarkand Global PLC.
00:10:00
Advance Auto Parts CEO Tom Greco on Q2 Earnings, Pre-Pandemic Performance, and Electric Vehicle Demand | Tom Greco, CEO, Advance Auto Parts.
00:10:00
Michael Klein, Chairman & CEO of iCAD, Inc., discusses corporate highlights, uniqueness, and future plans for compounding success during an interview with SNNLive.|Michael Klein, Chairman & CEO of iCAD, Inc
00:10:00
Marc Halbfinger, CEO of PCCW Global, delivers a compelling testimonial at PTC, highlighting his vision and leadership.|Mr Li was appointed an Executive Director and the Chairman of PCCW
00:10:00
helping to build enduring companies that create outsized financial & societal impact|Anand Chandrasekaran,Partner,General Catalyst
00:10:00
Adapting Strategies: Market Lessons and Future Outlooks | Cliff Asness, Chief Investment Officer , AQR Capital.
00:10:00
Ultra Lithium Reports Promising Drill Results and Eyes Strategic Partnerships